
Amino Collective is an early-stage venture capital firm founded in 2020, headquartered in Berlin with offices in London, investing at the intersection of health, bio, and AI. The firm backs founders developing life-changing ideas in areas such as AI-driven drug discovery, digital therapeutics, clinical trial platforms, and synthetic biology.
31% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 7 prior). Their most common stage is series-a (55% of deals). Average disclosed round size is $20.7M (across 17 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
29 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $15M | Mar 2026 | |
| Pre-Seed | $3.3M | Jan 2026 | |
| Series B | $100M | Jan 2026 | |
| Series A | — | Jun 2025 | |
| Series A | $35M | Jun 2025 | |
| Series A | $25M | May 2025 | |
| Series A | $25M | May 2025 | |
| Seed | — | Apr 2025 | |
| Series A | $18M | Mar 2025 | |
| Series B | $55M | Jan 2025 | |
| Series A | — | Jan 2025 | |
| Series A | $12.0M | Mar 2024 | |
| Series A | $12M | Jan 2024 | |
| Series A | — | Aug 2023 | |
| Series A | — | Oct 2022 | |
| Series A | $12M | Mar 2022 | |
| Series A | — | Dec 2021 | |
| Series A | $12M | Jun 2021 | |
| Series A | — | Jan 2021 | |
| AAllcyte | Unknown | $6M | Jan 2021 |
| Series B | — | — | |
| Seed | $13M | — | |
| Pre-Seed | $3M | — | |
| Seed | — | — | |
| Seed | $3M | — |
Page 1 of 2
Top Co-Investors
Creandum4 shared
Y Combinator4 shared
Seedcamp3 shared
firstminute capital3 shared
Salica Investments3 shared
Visionaries3 shared
Point Nine Capital3 shared
Earlybird Venture Capital3 shared
Hummingbird Ventures3 shared
Redalpine3 shared
42CAP3 shared
Octopus Ventures2 shared
Calm/Storm Ventures2 shared
Presight Capital2 shared
Balderton Capital2 shared
Northzone2 shared
Kinnevik2 shared
8VC2 shared
WS Investment Company2 shared
We Venture Capital2 shared
Last updated: 7 October 2026